Latest news
Wall Street Zen Downgrades Cytokinetics (NASDAQ:CYTK) to Sell - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTCYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong - TradingViewTradingView · Fri, 07 Aug 2026 18:22:00 GMTCytokinetics (CYTK) Releases Q2 2026 Earnings: Revenue Beats but Losses Persist - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 21:10:00 GMTCytokinetics' aficamten trial met both primary endpoints; Q4 filing expected - Stock TitanStock Titan · Thu, 06 Aug 2026 20:00:00 GMTJanus Henderson Group PLC Acquires 25,909 Shares of Cytokinetics, Incorporated $CYTK - MarketBeatMarketBeat · Tue, 04 Aug 2026 09:23:19 GMTInsider Sale: EVP of $CYTK Sells 14,000 Shares - Quiver QuantitativeQuiver Quantitative · Thu, 30 Jul 2026 20:38:00 GMTAndrew Callos of Cytokinetics Inc (CYTK) sells 14,000 shares after exercising options - Stock TitanStock Titan · Thu, 30 Jul 2026 20:26:43 GMTCytokinetics (CYTK) insider schedules 24,000-share option-related stock sale - Stock TitanStock Titan · Thu, 30 Jul 2026 20:23:12 GMT